A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer

NCT01926769•Gachon University Gil Medical Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Previously Treated Advanced Colorectal Cancer

Interventions

Metformin

Locations

South Korea

Locations (1)

Gachon University Gil Medical Center

Incheon, South Korea

Key Dates

Start Date

February 1, 2012

Primary Completion Date

December 1, 2014

Completion Date

December 1, 2014

Last Updated

May 15, 2018

Sponsors

Lead Sponsor

Gachon University Gil Medical Center

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 15, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions